A major challenge in the R2 and R2* methods for mapping liver iron content is that they can be confounded by fat, fibrosis and other changes in cellularity that are known to contribute to R2 and R2*. In this paper, the fat contribution to liver susceptibility was estimated and removed from the measured liver susceptibility with validation on a gadolinium-fat-water phantom. In patients, fat-corrected QSM was found to be insensitive to liver diseases including fat and tumor, which had extensive effects on R2*. Therefore, QSM can overcome confounding factors in R2* for mapping liver iron content.
This abstract and the presentation materials are available to members only; a login is required.